 |
 |

The Role of Prostacyclin and Thromboxane in Sepsis and Septic Shock
Richard H. Carmona, MD;
Tanny C. Tsao, MS;
Donald D. Trunkey, MD
Arch Surg. 1984;119(2):189-192.
Abstract
Prostacyclin, or prostaglandin I2 (PGI2), and thromboxane A2 (TXA2) are potent, endogenously produced, vasoactive substances that have been implicated as mediators in the pathophysiologic nature of septic shock. We investigated the contribution and production of PGI2 and TXA2 in sepsis and septic shock, using an intact rabbit model and an in vitro rabbit isolated cardiac perfusion model. Continuous hemodynamic monitoring of both experimental models, along with serial radioimmunoassays of the metabolites of PGI2 and TXA2, indicated that myocardial depression is a common finding in subjects with septic shock and that septic shock causes a suppression of PGI2 production while augmenting TXA2 production. In addition, PGI2 and TXA2 were mediators of some cardiovascular changes in septic shock but were themselves not the toxic factor(s) responsible for the associated myocardial depression.
(Arch Surg 1984;119:189-192)
Author Affiliations
From the University of California—San Francisco Medical School and the Department of Surgery, San Francisco General Hospital.
Footnotes
Accepted for publication Sept 16, 1983.
Read before the Third Annual Meeting of the Surgical Infection Society, Fort Lauderdale, Fla, May 10, 1983.
Reprint requests to Surgical Service, San Francisco General Hospital, San Francisco, CA 94110 (Dr Trunkey).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Role of Thromboxane in Producing Hepatic Injury During Hepatic Stress
Yokoyama et al.
Arch Surg 2005;140:801-807.
ABSTRACT
| FULL TEXT
Thromboxane A2-Receptor Blockade and Prostacyclin in Porcine Escherichia coli Shock
Svartholm et al.
Arch Surg 1989;124:669-672.
ABSTRACT
Myocardial Dysfunction in Septic Shock
Carmona et al.
Arch Surg 1985;120:30-35.
ABSTRACT
|